Archives
-
Cell Counting Kit-8 (CCK-8) for Viability
2026-08-26
Cell Counting Kit-8 (CCK-8) uses WST-8 conversion to quantify viable-cell-associated metabolic activity with a water-soluble formazan readout. The cck8 workflow is useful for proliferation and cytotoxicity comparisons, but its signal requires biological and chemical controls before it is interpreted as cell number or mechanism.
-
Zosuquidar (LY335979) in P-gp MDR Workflows
2026-08-24
Zosuquidar (LY335979) 3HCl provides a selective way to test whether P-glycoprotein drives chemotherapy resistance rather than merely increasing cytotoxic exposure. This guide converts that mechanism into reproducible cell-based sensitization, intracellular accumulation, and translational pharmacokinetic workflows.
-
CCK-8 Antagonism of Electroacupuncture Analgesia
2026-08-24
The 1986 reference study showed that centrally administered CCK-8 dose-dependently antagonized electroacupuncture analgesia without changing baseline nociception, while CCK-8 antiserum delayed or reversed electroacupuncture tolerance. Its selective interaction with opioid-linked analgesia positioned endogenous CCK-8 as a candidate anti-opioid signal in the central nervous system.
-
ORM2–ZG16 Axis in Pancreatic Fibrosis
2026-08-23
A February 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis and links its activity to ZG16-dependent control of autophagy in pancreatic stellate cells. Genetic loss- and gain-of-function experiments, together with cellular flux assays, provide a mechanistic framework for evaluating antifibrotic interventions in caerulein-induced pancreatic injury.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-08-22
The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid dual-fluorescence readout for distinguishing viable-like, apoptotic-like, and necrotic-like cell populations in cell viability and cytotoxicity workflows. It is intended for fluorescence microscopy or flow cytometry, not for pathway elucidation or as a standalone confirmation of the molecular cause of cell death.
-
Catalpol and the Sirt6–ERα–FasL Axis in Osteoporosis
2026-08-22
This study identifies a bone-protective mechanism for Catalpol in estrogen deficiency: promotion of osteoclast apoptosis through Sirt6-dependent ERα deacetylation and FasL signaling. Its combination of an ovariectomized rat osteoporosis animal model, RANKL-induced osteoclast assays, and Sirt6 knockdown provides a useful framework for mechanistic replication and translational interpretation.
-
Recombinant Human Growth Hormone: Axis to Assay
2026-08-21
Recombinant Human Growth Hormone can function as more than a proliferation stimulus: it enables causal analysis of growth hormone receptor activation, IGFBP2, THBS1, and IGF-1 signaling. This article presents a differentiated assay strategy grounded in recent human chondrocyte research and practical reagent-quality considerations.
-
ORM2–ZG16 Autophagy Axis in Pancreatic Fibrosis
2026-08-20
A 2026 Pancreatology study identifies ORM2 as an endogenous inhibitor of chronic pancreatitis-associated fibrosis and links its activity to ZG16-dependent control of autophagy in pancreatic stellate cells. Genetic loss- and gain-of-function experiments suggest that the ORM2–ZG16 interaction is mechanistically important, while the model design provides a useful framework for studying antifibrotic interventions.
-
Ciprofloxacin, RSL3, and Mitochondrial Ferroptosis
2026-08-19
The reference study identifies a context-dependent role for ciprofloxacin in ferroptosis: rather than suppressing every ferroptotic stimulus, it enhances RSL3-induced death by linking topoisomerase 2β inhibition to mitochondrial DNA stress, STING1–CAV2 signaling, and mitochondrial Zn2+ accumulation. The findings provide a mechanistic framework for interpreting antibiotic–drug interactions in cancer cells and emphasize the need to pair cell viability measurement with orthogonal ferroptosis endpoints.
-
Z-IETD-FMK Workflows for Caspase-8 Research
2026-08-18
Z-IETD-FMK enables targeted interrogation of caspase-8 in activated T cells, NF-κB signaling, and TRAIL-driven cell death. This practical guide connects inhibitor handling with time-resolved assay design, mechanistic controls, and troubleshooting for immune and cancer research.
-
Luminescent ATP Cell Viability Assay Kit I for GBM
2026-08-18
Rapidly quantify viable glioblastoma cells with luciferase luminescence detection across a 10–30,000-cell linear range. This workflow helps distinguish reduced proliferation from overt cytotoxicity when evaluating intracellular p21 peptide delivery.
-
Demethyleneberberine in Neurodegenerative Disease
2026-08-17
This 2022 review proposes Demethyleneberberine (DMB), a berberine metabolite, as a neuroprotective candidate acting through interconnected oxidative-stress, neuroinflammatory, mitochondrial, NF-κB, MAPK, and AMPK mechanisms. Its main value is hypothesis generation: it organizes pharmacological evidence into a mechanistic framework while emphasizing that direct disease-specific validation remains necessary.
-
Iptacopan (LNP023) in Complement Research
2026-08-16
Iptacopan (LNP023) enables selective, reversible alternative-pathway inhibition across serum, hemolysis, deposition, and disease-model workflows. Its proximal mechanism helps researchers connect C3bBb blockade with PNH-relevant readouts such as C3 deposition, C5b-9 formation, LDH, and transfusion burden.
-
PPP1R3G–PP1γ Activates RIPK1 Cell Death
2026-08-15
The reference study identifies PPP1R3G as a regulatory subunit that recruits PP1γ to TNF receptor complex I, enabling dephosphorylation and activation of RIPK1. Genetic, biochemical, pharmacological, and mouse experiments connect this phosphatase-controlled checkpoint to RIPK1-dependent apoptosis, type I necroptosis, and TNF-induced systemic inflammation.
-
Miltefosine: From PI3K Inhibition to Myelopoiesis
2026-08-14
Miltefosine is a mechanistically versatile PI3K/Akt pathway modulator with emerging relevance to neutrophil differentiation research. This article explains how to separate Akt phosphorylation inhibition, Ras/MEK/ERK-dependent maturation, and cytotoxicity when designing translational assays.